![]() |
Computed Tomography
Gross Pathology Specimen
HistopathologyCT images demonstrate a dilated right intrahepatic biliary system and pneumobilia in the left intrahepatic ducts (figure 1). There is a 3.8 x 4.7cm irregular mass at the bifurcation of the right and left hepatic ducts that is hypovascular relative to the liver, enhances heterogeneously, and has a cystic/necrotic subcapsular component (figure 2). This mass invades the stomach (figure 3).
The gross sample was collected at autopsy. The probe in the image is inserted into the ampulla of Vater, which connects to a common hepatic bile duct stent, which follows into the left hepatic biliary system. This has been dissected out, revealing a necrotic cavity. One cholelith was identified within the cavity. Approximately 2 cm proximal along the biliary tree, there is a 3-cm, well-circumscribed mass. Proximal to the mass, the right hepatobiliary system is quite dilated. Histopathology reveals atypical, pleiomorphic cells and bacterial forms in the necrotic cavity. The bacterial forms were positive for enterococcus. The main findings are:
Radiology Discussion
Cholangiocarcinoma is the most common primary malignancy of the bile ducts and the second most prevalent liver cancer. The average age at onset is 60-65 years, and it strikes men slightly more often than women (1.5:1).
The most common presenting symptoms are unexplained weight loss and jaundice. Predisposing factors include UC, PSC, choledochal cysts, Caroli disease, thoratrast, and parasitic infestation (Clonorchis sinensis ).
The macroscopic appearance can be mass-like, infiltrative, or polypoid. Mass-like cholangiocarcinoma (intrahepatic cholangiocarcinoma) is characterized by a low attenuation mass showing peripheral enhancement and focal ductal dilatation around the tumor. These findings are also common in hepatic metastases.
Infiltrative cholangiocarcinoma is characterized by a focally thickened ductal wall and proximal biliary dilatation. Similar findings are associated with benign stricture.
Polypoid cholangiocarcinoma is characterized by a dilated bile duct filled with polypoid soft tissue and proximal biliary dilatation. These findings are also present with benign biliary tumors, such as papilloma and adenoma.
Cholangiocarcinoma is treated by resection. Complete resection is the only possibility of a cure. The overall 5-year survival rate is 1-5%; this increases to 10-50% following an attempt at resection. The goal of radiologic assessment is to:
Cholangiocarcinoma cannot be resected if any of the following are found:
Lee WJ et al. Radiologic Spectrum of Cholangiocarcinoma; Emphasis on Unusual Manifestations and Differential Diagnoses. Radiographics 2001; 21:S97-S116.
Lee JK et al. Computed Body Tomography with MRI Correlation 3rd ed. Lipppincott Williams and Wilkins, Philadelphia, 1998.
Weissleder R et al. Primer of Diagnostic Imaging, 2nd ed. Mosby, St. Louis, 1997.
Dear Visitors: Nothing on this World Wide Web site should be considered medical advice. Only your own doctor can help you make decisions about your medical care. It is not the policy of the Brigham and Women's Hospital Department of Radiology to provide consultation on the World Wide Web or via e-mail. If you have a specific medical question or are seeking medical care, please call the Brigham and Women's Hospital toll-free physician referral line at 1-800-294-9999.
Is this a mirrored page?
The official homepage of the BrighamRAD Teaching Case Database is http://brighamrad.harvard.edu/education/online/tcd/tcd.html
Contact the BrighamRAD Design Team for additional information about this website.